<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title><![CDATA[EC21 Product Catalogs - clinic analysis]]></title>
<link><![CDATA[https://www.ec21.com/ec-market/clinic_analysis--0548/1/clinic analysis.html]]></link><item>
<title><![CDATA[Organic Curcumin Extract]]></title><link><![CDATA[https://hzlbio.en.ec21.com/Organic_Curcumin_Extract--11909358_11909372.html]]></link><description><![CDATA[Analysis Item
Standard
Result
Method/ Reference
Physical
Appearance Color
Orange Yellow Powder
Orange Yellow Powder
Visual
Odor
Characteristic
Characteristic
Sensory
Moisture,g/100g
≤5.0%
2.30%
CP2]]></description><pubDate><![CDATA[20240713]]></pubDate></item>
<item>
<title><![CDATA[Tomato Extract Lycopene]]></title><link><![CDATA[https://comextbiotech.en.ec21.com/Tomato_Extract_Lycopene--10504235_10507457.html]]></link><description><![CDATA[analysis of the literature and published on Curr Med Chem in 2011.
According to the article several reports have appeared in support of the role of lycopene in the prevention of CVD, mostly based on ]]></description><pubDate><![CDATA[20170815]]></pubDate></item>
<item>
<title><![CDATA[Ginseng P.E.]]></title><link><![CDATA[https://huataibiop.en.ec21.com/Ginseng_P.E.--1358103_4316821.html]]></link><description><![CDATA[Analysis 
Items
Standard
Typical 
Ginsenosides (UV) 
&gt;80% 
80.20%
Loss on Drying
&lt;5.0%
3.65%
Residue on Ignition
&lt;5.0%
2.10%
Heavy metals
&lt;10 ppm
Complies
Residual Solvents
Eur. Pharm.
Complies
Micro]]></description><pubDate><![CDATA[20160317]]></pubDate></item>

</channel>
</rss>